Back to Search
SIDNEY ROSENBERG, MD
MD
Ophthalmology Physician
NPI: 1699734871Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
MD097291(NY)
Research & Publications (20)
Supporting the patient's role in guideline compliance: a controlled study.
PMID 18999908·Am J Manag Care·2008
8-other
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
PMID 19423728·Blood·2009
8-other
Life, death, differentiation, and the multicellularity of bacteria.
PMID 19282973·PLoS Genet·2009
6-review
Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.
PMID 19389403·J Immunol Methods·2009
8-other
Frequent mutations in the MITF pathway in melanoma.
PMID 19422606·Pigment Cell Melanoma Res·2009
8-other
The fate of the seminal vesicle remnant after proximal transection or ligation: an animal model.
PMID 19157442·J Urol·2009
7-preclinical
"Dial-an-ROI?" changing basic variables impacts cost trends in single-population pre-post ("DMAA type") savings analysis.
PMID 19216675·Popul Health Manag·2009
8-other
Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
PMID 19265475·Hum Gene Ther·2009
8-other
DinB upregulation is the sole role of the SOS response in stress-induced mutagenesis in Escherichia coli.
PMID 19270270·Genetics·2009
8-other
Adoptive cell therapy for the treatment of patients with metastatic melanoma.
PMID 19304471·Curr Opin Immunol·2009
6-review
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.
PMID 19330028·Nat Genet·2009
8-other
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
PMID 19398903·Anticancer Drugs·2009
7-preclinical
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma.
PMID 19410956·Ophthalmology·2009
5-case
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
PMID 18677478·Cancer Immunol Immunother·2009
8-other
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
PMID 19118044·Clin Cancer Res·2009
7-preclinical
A role for cFLIP in B cell proliferation and stress MAPK regulation.
PMID 19109151·J Immunol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 339 MERRICK ROAD
LYNBROOK, NY 11563 - Phone
- (516) 887-1525
Quick Facts
- NPI
- 1699734871
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile